Context Therapeutics Inc.
CNTX
$2.36
-$0.12-4.84%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.17% | 12.31% | -84.24% | -29.60% | -11.52% |
| Total Depreciation and Amortization | 50.46% | 43.40% | 27.52% | 7.83% | -9.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.00% | -91.41% | 1,644.44% | 1,376.68% | 1,284.85% |
| Change in Net Operating Assets | 280.74% | 215.43% | 167.77% | -683.30% | -295.76% |
| Cash from Operations | -81.26% | -32.42% | 3.81% | 22.64% | 30.84% |
| Capital Expenditure | -364.38% | -364.38% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 86.44% | 100.00% | -- | -- | -- |
| Cash from Investing | 86.22% | 99.77% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -84.67% | -84.67% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.01% | -84.68% | -84.73% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.55% | -112.46% | -123.59% | 502.76% | 479.99% |